Vietnam Antimicrobial Susceptibility Testing Market Outlook to 2028

Vietnam Antimicrobial Susceptibility Testing Market Overview

The Vietnam antimicrobial susceptibility testing (AST) Market has experienced substantial growth, this is reflected by the global AST market size valued at USD 3.3 Billion in 2023. This growth is driven by the rising prevalence of infectious diseases, increasing antibiotic resistance, and the expanding healthcare infrastructure in the country.

The key players in the Vietnam Antimicrobial Susceptibility Testing Market include bio Mérieux SA, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Danaher Corporation, and Bio-Rad Laboratories. These companies dominate the market with their comprehensive product portfolios, strong distribution networks, and continuous innovation in AST technologies.

In January 2024, Becton, Dickinson and Company announced a strategic partnership with Vietnam's Ministry of Health to implement advanced AST systems in 50 major hospitals nationwide. This initiative, valued at USD 10 million, aims to improve diagnostic capabilities and combat antimicrobial resistance effectively.

In 2023, the northern region, including Hanoi, held a dominant market share, driven by advanced healthcare infrastructure and a high concentration of major hospitals and diagnostic laboratories.

Vietnam Antimicrobial Susceptibility Testing Market Segmentation

The Vietnam antimicrobial susceptibility testing market is segmented into product type, end-users, and region.

By Product Type: The Vietnam antimicrobial susceptibility testing market is segmented by product type into manual AST products, automated AST products, and consumables. In 2023, automated AST systems held a dominant market share, attributed to their high accuracy, efficiency, and ability to handle large volumes of samples.

By End-Users: The Vietnam AST market is segmented by end-users into hospitals, diagnostic laboratories, and research institutes. In 2023, hospitals held the largest market share, primarily due to the high volume of patient samples processed and the critical need for accurate and timely diagnostics in hospital settings.

By Region: The market is segmented by region into North, South, East, and West Vietnam. In 2023, North Vietnam including Hanoi dominates due to the presence of major hospitals and diagnostic laboratories in this region, along with ongoing initiatives to enhance diagnostic capabilities, contributes to its leading market share.

Vietnam Antimicrobial Susceptibility Testing Market Competitive Landscape

Company

Establishment Year

Headquarters

Thermo Fisher Scientific Inc.

1956

Waltham, Massachusetts

Becton, Dickinson and Company

1897

Franklin Lakes, New Jersey

bio Mérieux SA

1963

Marcy-l'Étoile, France

Danaher Corporation

1969

Washington, D.C.

Bio-Rad Laboratories, Inc.

1952

Hercules, California

Thermo Fisher Scientific: Thermo Fisher Scientific's introduction of the automated AST system in December 2023, reducing susceptibility testing time from 24 hours to 6 hours, marks an advancement. This innovation is expected to improve diagnostic accuracy and patient management in Vietnamese healthcare facilities.

Siemens Healthineers: Siemens Healthineers' establishment of a new diagnostic laboratory in Ho Chi Minh City in June 2023, equipped with advanced AST systems, represents a strategic expansion. This facility enhances the region's diagnostic capabilities, supporting timely and accurate disease management.

Vietnam Antimicrobial Susceptibility Testing Market Analysis

Vietnam Antimicrobial Susceptibility Testing Market Growth Drivers:

Increasing Incidence of Infectious Diseases: In 2023, Vietnam reported over 250,000 cases of bacterial infections, increasing the demand for antimicrobial susceptibility testing (AST). The rise in infections, such as multidrug-resistant tuberculosis (MDR-TB) with over 12,000 reported cases, underscores the need for precise and timely diagnostics to guide effective treatment.

Expansion of Healthcare Infrastructure: Vietnam's healthcare sector saw investments in 2023, with over 20 new hospitals and 50 upgraded healthcare facilities incorporating advanced diagnostic tools, including AST systems. This expansion enhances the accessibility and adoption of AST across the country.

Rising Demand for Personalized Medicine: The increasing focus on personalized medicine, where treatment is tailored based on individual patient profiles, has bolstered the demand for AST. In 2023, around 40,000 personalized treatment plans in Vietnam relied on precise antimicrobial susceptibility data, highlighting the critical role of AST in modern healthcare.

Vietnam Antimicrobial Susceptibility Testing Market Challenges:

High Cost of Advanced Testing Equipment: In 2023, the average cost of a comprehensive AST system was around USD 50,000, which is prohibitive for many smaller healthcare facilities. The high cost of equipment and consumables limits the widespread adoption of AST systems, particularly in rural and underfunded areas.

Regulatory Hurdles: Stringent regulatory requirements for the approval and implementation of new diagnostic technologies can delay the deployment of AST systems. In 2023, several diagnostic companies reported delays of up to 18 months in getting regulatory approval for new AST products, impacting market growth.

Vietnam Antimicrobial Susceptibility Testing Market Government Initiatives:

National Action Plan on Antimicrobial Resistance (AMR) 2023-2025:The Vietnamese government launched this plan in 2023 with funding of USD 15 million to combat antimicrobial resistance. The plan includes initiatives to improve diagnostic capabilities, promote appropriate use of antibiotics, and enhance infection control measures across healthcare facilities.

Government Healthcare Initiatives: The Vietnamese government allocated USD 15 million in 2023 to combat antimicrobial resistance through the National Action Plan on Antimicrobial Resistance (AMR) 2023-2025. This plan includes improving diagnostic infrastructure and promoting the adoption of AST systems in healthcare facilities, thereby driving market growth.

Vietnam Antimicrobial Susceptibility Testing Future Market Outlook

The Vietnam Antimicrobial Susceptibility Testing market is expected to grow in the coming years. The market is also likely to shift towards more organized with established players and online platforms expanding their reach.

Vietnam Antimicrobial Susceptibility Testing Future Market Trends

Integration of Artificial Intelligence in AST: By 2028, artificial intelligence (AI) is expected to play a crucial role in AST, improving the speed and accuracy of susceptibility testing. AI algorithms will analyze large datasets to predict antibiotic resistance patterns, enabling more precise and personalized treatment decisions.

Expansion of Point-of-Care Testing (POCT): The adoption of point-of-care testing (POCT) for antimicrobial susceptibility is projected to increase, making diagnostics more accessible in rural and remote areas. By 2028, portable AST devices will be widely used in primary healthcare settings, improving early diagnosis and treatment outcomes.
Please Note: It will take 5-7 business days to complete the report upon order confirmation